340 related articles for article (PubMed ID: 20974285)
1. Metal-based drugs for malaria, trypanosomiasis and leishmaniasis: recent achievements and perspectives.
Navarro M; Gabbiani C; Messori L; Gambino D
Drug Discov Today; 2010 Dec; 15(23-24):1070-8. PubMed ID: 20974285
[TBL] [Abstract][Full Text] [Related]
2. Parasitology. Drugs to combat tropical protozoan parasites.
Gelb MH; Hol WG
Science; 2002 Jul; 297(5580):343-4. PubMed ID: 12130767
[No Abstract] [Full Text] [Related]
3. Natural products as trypanocidal, antileishmanial and antimalarial drugs.
Fournet A; Muñoz V
Curr Top Med Chem; 2002 Nov; 2(11):1215-37. PubMed ID: 12171582
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of leishmaniasis and human trypanosomiasis: status and new developments].
Kayser O; Croft SL; Kolodziej H
Pharm Unserer Zeit; 1999 Jul; 28(4):177-85. PubMed ID: 10443145
[No Abstract] [Full Text] [Related]
5. Complementary medicinal chemistry-driven strategies toward new antitrypanosomal and antileishmanial lead drug candidates.
Cavalli A; Lizzi F; Bongarzone S; Belluti F; Piazzi L; Bolognesi ML
FEMS Immunol Med Microbiol; 2010 Feb; 58(1):51-60. PubMed ID: 19845762
[TBL] [Abstract][Full Text] [Related]
6. Metal complexes as chemotherapeutic agents against tropical diseases: trypanosomiasis, malaria and leishmaniasis.
Sánchez-Delgado RA; Anzellotti A
Mini Rev Med Chem; 2004 Jan; 4(1):23-30. PubMed ID: 14754440
[TBL] [Abstract][Full Text] [Related]
7. Metal complexes as chemotherapeutic agents against tropical diseases: malaria, trypanosomiasis, and leishmaniasis.
Sánchez-Delgado RA; Anzellotti A; Suárez L
Met Ions Biol Syst; 2004; 41():379-419. PubMed ID: 15206123
[No Abstract] [Full Text] [Related]
8. Chemotherapy of trypanosomiases and leishmaniasis.
Croft SL; Barrett MP; Urbina JA
Trends Parasitol; 2005 Nov; 21(11):508-12. PubMed ID: 16150644
[TBL] [Abstract][Full Text] [Related]
9. Computer-Aided Drug Discovery Approaches against the Tropical Infectious Diseases Malaria, Tuberculosis, Trypanosomiasis, and Leishmaniasis.
Njogu PM; Guantai EM; Pavadai E; Chibale K
ACS Infect Dis; 2016 Jan; 2(1):8-31. PubMed ID: 27622945
[TBL] [Abstract][Full Text] [Related]
10. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
Werbovetz K
Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
[TBL] [Abstract][Full Text] [Related]
11. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
[TBL] [Abstract][Full Text] [Related]
12. Recent Progress in the Development of Indole-Based Compounds Active against Malaria, Trypanosomiasis and Leishmaniasis.
Pacheco PAF; Santos MMM
Molecules; 2022 Jan; 27(1):. PubMed ID: 35011552
[TBL] [Abstract][Full Text] [Related]
13. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative.
Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD
Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial peptides for leishmaniasis.
Cobb SL; Denny PW
Curr Opin Investig Drugs; 2010 Aug; 11(8):868-75. PubMed ID: 20721829
[TBL] [Abstract][Full Text] [Related]
15. State-of-the-art Review on the Antiparasitic Activity of Benzimidazolebased Derivatives: Facing Malaria, Leishmaniasis, and Trypanosomiasis.
Francesconi V; Rizzo M; Schenone S; Carbone A; Tonelli M
Curr Med Chem; 2024; 31(15):1955-1982. PubMed ID: 37718524
[TBL] [Abstract][Full Text] [Related]
16. Boron-based drugs as antiprotozoals.
Jacobs RT; Plattner JJ; Keenan M
Curr Opin Infect Dis; 2011 Dec; 24(6):586-92. PubMed ID: 22001943
[TBL] [Abstract][Full Text] [Related]
17. Topoisomerases of kinetoplastid parasites as potential chemotherapeutic targets.
Das A; Dasgupta A; Sengupta T; Majumder HK
Trends Parasitol; 2004 Aug; 20(8):381-7. PubMed ID: 15246322
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Novel compounds to combat trypanosomatid infections: a medicinal chemical perspective.
González M; Cerecetto H
Expert Opin Ther Pat; 2011 May; 21(5):699-715. PubMed ID: 21428846
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of glycosyl-isoindigo derivatives against the pathogenic agents of tropical diseases (malaria, Chagas disease, leishmaniasis and human African trypanosomiasis).
Bouchikhi F; Anizon F; Brun R; Moreau P
Bioorg Med Chem Lett; 2011 Nov; 21(21):6319-21. PubMed ID: 21937228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
